“You could have an incredible drug that works, but if payers won’t pay, it will never reach the patients who need it."

​

Prof. Chris McCabe

 

RetInnovate was born from this very mantra—educating and bridging the gap between scientific innovation and commercial success. This bootcamp brings together experts in preclinical modelLing, regulatory strategy, IP, health economics, and investment to give retinal disease innovators the tools to improve investor onboarding and increase success — not just in treating patients, but in navigating the different market payers.

​

Dr. James Bojdo

​

Programme Director, Retinnovate